+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Cure JM Mental Health Grant

Cure JM Foundation

The Cure JM Foundation (Cure JM) announces its Request for Proposals for 2026 for advancing mental health to improve the lives of children and families living with juvenile myositis Cure JM is a 501(c)(3) non-profit organization established in 2003.

The mission of Cure JM is to find better treatments and a cure for Juvenile Myositis and improve the lives of families affected by JM. Approximately 2 to 4 children in a million in the United States are diagnosed with JM each year.

In 2026, Cure JM has committed to funding a mental health grant up to $15,000 for up to 18 months.

Grant Application Process Proposals should be submitted electronically as one single PDF file to suzanne.edison@curejm.org and must be received by the submission deadline for applications stated in the research announcement timeline. (See Grant Application for specific information.)

Project Purpose and Description The proposal should outline and detail the following:

● What is the project description—goals and mechanisms for promoting more mental health care for the JM patients and families in your clinic/care

● Who will be the lead PI on the project

● Who else will be involved in the project

● What are the proposed time commitments for the project and for each project member

● Timeline for the project as a whole

● How will the end product be disseminated

● What would be your Next Steps or Future Vision

● What is the Budget for the project

AI Based Application Success Predictor

1. Direct relevance to juvenile myositis research (highest predictor)

This is the most important factor.

Cure JM specifically funds projects focused on:

Juvenile dermatomyositis (JDM)
Juvenile polymyositis
Juvenile myositis disease mechanisms
Biomarker discovery
Disease progression
Treatment response
Long-term outcomes
Precision medicine approaches

Projects must clearly address an important question related to juvenile myositis.

2. Potential to improve diagnosis, treatment, or outcomes (very high predictor)

Cure JM's mission is strongly patient-centered.

Competitive proposals typically demonstrate potential to:

Improve clinical care
Enable earlier diagnosis
Predict disease activity
Improve treatment selection
Reduce complications
Improve long-term quality of life

Projects with a clear pathway to patient benefit are particularly attractive.

3. Innovative and translational science (very high predictor)

Recent Cure JM-funded projects have focused on:

Novel biomarkers
Molecular profiling
Precision medicine
Immune mechanisms
Disease prediction tools

The Foundation favors research that can move discoveries toward clinical application rather than purely descriptive studies.

4. Strong preliminary data and scientific feasibility

Although Cure JM supports innovative projects, successful applications generally demonstrate:

Strong scientific rationale
Preliminary findings
Feasible methodology
Appropriate study design
Realistic milestones

Reviewers want confidence that the proposed work can produce meaningful results within the grant period.

5. Investigator expertise in rheumatology, immunology, or myositis research

Competitive applicants often have expertise in:

Pediatric rheumatology
Immunology
Autoimmune disease research
Muscle biology
Translational medicine

Prior publications and experience in inflammatory or autoimmune diseases strengthen applications.

6. Strong mentorship and protected research time

For junior investigators, mentorship is a major success predictor.

Cure JM grant guidance indicates preference for applicants with protected research effort (often at least 25%) and a supportive research environment. Competitive applications typically include:

Experienced mentors
Dedicated research time
Access to patient cohorts
Institutional support

7. Ability to generate future external funding

Cure JM grants frequently serve as seed funding.

Projects that can generate:

Pilot data
New biomarkers
Proof-of-concept findings
Future NIH or foundation grant applications

are particularly attractive because they expand the long-term impact of Cure JM's investment.

8. Collaboration and access to JM patient populations

Because juvenile myositis is a rare disease, strong applications often involve:

Multi-center collaborations
Patient registries
Biobanks
International research networks
Established JM cohorts

Access to sufficient patient samples or clinical data significantly strengthens feasibility.

9. Commitment to the juvenile myositis field

Cure JM aims to build a sustainable research community around JM.

Strong applicants often demonstrate:

Prior JM-related publications
Participation in myositis networks
Pediatric rheumatology involvement
Long-term commitment to rare autoimmune disease research

Specialties

Mental Health

Eligibility Requirements

Applicants must hold a Ph. D. or M.D. degree or equivalent and work in an accredited medical school, university, hospital, or research institute, which must agree to supply the clinical and/or laboratory facilities. Grant applications are called for across programs relating to all aspects of; basic research, clinical trials, translational studies, diagnosis, and clinical care of juvenile myositis. A pertinent but not exhaustive list of priorities includes:

● Clinical protocols for assessment of mental health for patients or caregivers

● Clinical interventions for mental health support

● Novel diagnostic strategies, including the development of biomarkers

● If application includes disease populations other than JM patients, applicants must have additional funding from other sources.

Sponsor Details

Sponsor Institute/Organizations: Cure JM Foundation

Sponsor Type: Corporate/Non-Profit

Address: 19309 WINMEADE DRIVE, SUITE 204 LEESBURG, VA 20176

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity